期刊文献+

三种HCV RNA荧光定量PCR检测试剂的结果分析及应用比较 被引量:4

Comparison of application of three types of HCV-RNA fluorescent quantitative PCR detection reagents
下载PDF
导出
摘要 目的:比较3种丙型肝炎病毒(HCV)RNA荧光定量PCR检测试剂的临床应用性能。方法采用国产 A 试剂(磁珠分离法)、国产 B 试剂(荧光探针法)和目前国际临床广泛应用的 C试剂(内标法)同时检测110例丙型肝炎患者临床血液样本及梯度稀释的强阳性标本,从试剂间的相关性、检测灵敏度、特异度等对结果进行对比分析。结果A 和 B、A 和 C、B 和 C 试剂间的相关系数分别为0.845、0.917、0.860(P 均<0.01)。在3种方法均有数值的58例标本中,3种试剂所检出的 HCV RNA 水平比较差异无统计学意义(P >0.05)。但在低病毒载量(<103 IU /ml)组中,3种试剂灵敏度比较差异有统计学意义(P <0.01),C 试剂灵敏度最高,A 试剂次之,B 试剂最低。当病毒载量在2.00×103~2.00×106 IU /ml 时,3种试剂的定量结果与理论值均有很好的相关性与重复性,其检测浓度的平均值与理论浓度的双对数线性相关系数分别为0.9983、0.9823、0.9999(P 均<0.01);当病毒载量为2.00×102 IU /ml 时,C 试剂的检测结果最接近,A 试剂次之,B 试剂未能检出。结论C 试剂作为国际上广泛应用于临床 HCV RNA 定量检测的试剂,优势明显;国产 A 试剂总体性能优于 B 试剂,且费用较国外试剂低廉,性价比较高。 Objective To compare the clinical application performance of three types of hepatitis C virus (HCV)-RNA fluorescent quantitative PCR detection reagents.Methods Domestic A reagent (magnet-ic bead separation method),domestic B reagent (fluorescence probe method)and C reagent currently widely used internationally (internal standard method)were adopted to detect 1 1 0 clinical blood in patients with Hep-atitis and strong-positive samples with gradient dilution.The correlation,sensitivity and specificity were statisti-cally compared among the results of three detection reagents.Results The correlation coefficient of three types of reagents was 0.845,0.91 7 and 0.860 (all P 〈0.01 ).In 58 samples detectable by three methods,no sig-nificant difference was found in HCV RNA level among three kinds of reagents (P 〉0.05).However,in the low viral load group (〈1 .00 ×1 0^3 IU /ml),the sensitivity significantly differed among three types of reagents with highest sensitivity in C reagent,followed by A and B reagents.In the viral load group (2.00 ×10^3 ~2.00 ×1 0^6 IU /ml),high levels of correlation and repeatability between the quantitative results and theoretical val-ues were observed in all reagents.The double logarithmic linear correlation coefficient of the mean and theoreti-cal concentration was 0.9983,0.9823 and 0.9999 (all P 〈0.01 ).When the viral load was 2.00 ×1 0^2 IU /ml,the detected concentration was the most similar to the theoretical concentration in C reagent,followed by A reagent and undetected in B reagent.Conclusions C reagent was superior to A and B reagents in the HCV-RNA fluorescent quantitative PCR detection.Compared with B reagent,A reagent exhibited better perform-ance.A reagent was cheaper compared with C reagent.Thus,A reagent could be used as a cost-effective HCV-RNA fluorescent quantitative PCR detection.
出处 《新医学》 2015年第6期373-377,共5页 Journal of New Medicine
基金 国家自然科学基金(31370907) 广东省自然科学基金(S2012010009155) 十二五国家科技重大专项(2012ZX10002007)
关键词 丙型肝炎 病毒 核酸定量 试剂 检测 Hepatitis C Virus Nucleic acid quantification Reagent Detection
  • 相关文献

参考文献9

  • 1Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis, 2010, 14 (1): 1-21.
  • 2Pas S, Molenkamp R, Schinkel J, Rebers S, Copra C, Seven-Deniz S, Thamke D, de Knegt R J, Haagmans BL, Schutten M. Performance evaluation of the new Roche co- bas AmpliPrep/cobas TaqMan HCV test, Version 2. O, for detection and quantification of hepatitis C virus RNA. J Clin Microbiol, 2013, 51 (1) : 238-242.
  • 3European Association for Study of Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus in- fection. J Hepatol, 2014, 60 (2): 392-420.
  • 4刘惠媛,陈志敏,曾健伟,黄宝国,刘晋新,石裕明.415例原发性肝癌患者的临床特点分析[J].新医学,2013,44(2):123-126. 被引量:17
  • 5Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 2011, 54 (4) : 1433-1444.
  • 6Beinhardt S, Rutter K, Stattermayer AF, Ferenci P. Re- visiting the predictors of a sustained virology response in the era of direct-acting anti'Sral therapy for hepatitis C vi- rus. Clin Infect Dis, 2013, 56 (1) : 118-122.
  • 7Harrington PR, Zeng W, Naeger LK. Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment. Hepatology, 2012, 55 (4): 1048-1057.
  • 8Ghany MG, Liang TJ. Current and future therapies for hepatitis C virus infection. N Engl J Med, 2013, 369 (7) : 679-680.
  • 9丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735

二级参考文献23

  • 1叶胜龙,陈荣新.2010年美国肝病学会肝细胞癌临床指南更新版解读[J].中国医学前沿杂志(电子版),2011,3(1):17-20. 被引量:13
  • 2Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 3Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 4Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 5Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 6Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 7Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 8Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 9Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
  • 10Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.

共引文献750

同被引文献39

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部